Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary…

Using real world data at @ExeterMed #ExeterDiabetes to explore the cost effectiveness of within-class switches. Bottom line - well controlled leave alone, otherwise try the switch. At worst no difference, at best improvements from the #TalkAboutDiabetes

My first bid at doing cost effective analysis based on live (less than 1 week old at time of analysis) real world data. Thank you to all the practices, CCGs and people with diabetes who allowed their anonymised data to be used. https://t.co/JwraxcKK1U